Group A Streptococcus: News and Literature


News:

Streptococcus News

Time Magazine: When Worry Hijacks the Brain
August 17, 2007

Dr. Koop: Strep Vaccine
March, 10, 2006

Newsweek: On The March To Eradicate Child Illness
June 10, 2005

NY Times: Can Strep Bring On an Anxiety Disorder?
December 14, 2004

Time Magasine: Is It Strep Throat?
April, 19, 2004

BBC News: Throat bug vaccine 'safe to use'
August 4, 2004

Time Magazine: Streptococcus Destroyer
September 23, 1935


Literature:

Banks, DJ, B Lei, and JM Musser. 2003. Prophage Induction and Expression of Prophage-Encoded Virulence Factors in Group A Streptococcus Serotype M3 Strain MGAS315. Infection and Immunity. 71(12):7079-7086.

Bisno AL, MO Brito, and CM Collins. 2003. Molecular basis of Group A streptococcal virulence. Lancet Infectious Diseases 3(4):191-200.

Brown J, DL Shriner, RA Schwartz, and CK Janniger. 2003. Impetigo: an update. International Journal of Dermatology. 42(4):251-255.

Catanzaro FJ, CA Stetson, AJ Morris, R Chamovitz, CH Rammelkamp Jr, BI Stolzer, and WD Perry. 1954. The role of Streptococcus in the pathogenesis of rheumative fever. The American Journal of Medicine. 17(6):749-56.

Center for Disease Control and Prevention. 2007. Group A Streptococcus. Retrieved November 20, 2007, from Centers for Disease Control and Prevention Web site: http://www.cdc.gov

Chatellier S, N Ihendyane, R G. Kansal, F Khambaty, H Basma, ANorrby-Teglund, DE Low, A McGeer, and M Kotb. 2000. Genetic Relatedness and Superantigen Expression in Group A Streptococcus Serotype M1 Isolates from Patients with Severe and Nonsevere Invasive Diseases. Infection and Immunity. 68(6):3523-3534.

Cone LA, DR Woodard, PM Schlievert, and GS Tomory. 1987. Clinical and bacteriologic observations of toxic shock-like syndrome due to Streptococcus pyogenes. New England Journal of Medicine. 317(3):146-149.

Dinkla K, M Rohde, WTM Jansen, EL Kaplan, GS Chhatwal, and SR Talay. 2003. Rheumatic fever-associated Streptococcus pyogenes isolates aggregate collagen. Journal of Clinical Investigation. 111:1905-1912.

Ebell MH, MA Smith, HC Barry, K Ives, and M Carey. 2000. Does this patient have strep throat? The Journal of the American Medical Association. 284:2912-2918.

Ewald P. 1994. Evolution of Infectious Diseases. Oxford University Press, New York.

Gaworzewska E and G Colman. 1988. Changes in the pattern of infection caused by Streptococcus pyogenes. Epidemiological Infections. 100(2):257-69.

Green RJ, DC Dafoe, and TA Raffin. 1996. Necrotizing fasciitis. Chest. 110:219-229.

Hauser AR, DL Stevens, EL Kaplan, and PM Schlievert. 1991. Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome. Clinical Microbiology. 29(8):1562-1567.

Haywood CT, A McGeer, and DE Low. 1999. Clinical Experience with 20 Cases of Group A Streptococcus Necrotizing Fasciitis and Myonecrosis: 1995 to 1997. Plastic and Reconstructive Surgery. 103(6):1567-1573.

Kaul R, A McGeer, DE Low, K Green, and B Schwartz. 1997. Population-based surveillance for Group A Streptococcal necrotizing fasciitis: Clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study. The American Journal of Medicine. 103(1):18-24.

Kotloff KL, SS Wasserman, KF Jones, S Livio, DE Hruby, CA Franke, and VA Fischetti. 2005. Clinical and Microbiological Responses of Volunteers to Combined Intranasal and Oral Inoculation with a Streptococcus gordonii Carrier Strain Intended for Future Use as a Group A Streptococcus Vaccine. Infection and Immunity. 73(4):2360-2366.

Mehta S, A McGeer, DE Low, D Hallett, DJ Bowman, SL Grossman, and TE Stewart. 2006. Morbidity and mortality of patients with invasive Group A streptococcal infections admitted to the ICU. Chest. 130(6):1679-1686.

McIsaac WJ, D White, D Tannenbaum, and DE Low. 1998. A clinical score to reduce unnecessary antibiotic us in patients with sore throat. Canadian Medical Association Journal. 158(1):175-183.

McNeil SA, SA Halperin, JM Langley, B Smith, A Warren, GP Sharratt, DM Baxendale, MA Reddish, MC Hu, SD Stroop, J Linden, LF Fries, PE Vink, and JB Dale. 2005. Safety and Immunogenicity of 26-valent Group A Streptococcus vaccine in healthy adult volunteers. Clinical Infectious Diseases. 2005(41):1114-1122.

Musser JM, AR Hauser, MH Kim, PM Schlievert, K Nelson, and RK Selander. 1991. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proceedings of the National Academy of Sciences of the United States of America. 88(7):2668-2672.

Musser JM, V Kapur, J Szeto, X Pan, DS Swanson, and DR Martin. 1996. Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease. Infection and Immunity. 63(3):994-1003.

Parker MT, AJ Tomlinson, and RE Willians. 1955. Impetigo contagiosa; the association of certain types of Staphylococcus aureus and of Streptococcus pyogenes with superficial skin infections. Journal of Hygiene (London). 53(4):458-473.

Patterson MJ. 1996. Streptococcus. In: Baron's Medical Microbiology (Baron S et al, eds.), 4th ed., University of Texas Medical Branch.

Stevens DL. 1995. Streptoccocal Toxic-Shock Syndrome: Spectrum of disease, pathogenesis, and new concepts in treatment. Emerging Infectious Diseases 1(3):69-78.

World Health Organization. 2007. Group A Streptococcus. Retrieved November 17, 2007, from World Health Organization Web site: http://www.who.int/en/